down arrow

Titan Biotech

  • Market Cap: Micro Cap
  • Industry: Chemicals
  • ISIN: INE150C01011
  • NSEID:
  • BSEID: 524717
INR
504.95
14.95 (3.05%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 4.61 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Solar Industries
Sumitomo Chemi.
Alufluoride
Godrej Industrie
Mangalam Organic
Gujarat Fluoroch
Titan Biotech
Lords Chloro
Deepak Nitrite
Aarti Surfactant
OCCL
Why is Titan Biotech Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate 18.00% of over the last 5 years
2
Negative results in Dec 24
  • PAT(Q) At Rs 4.39 cr has Fallen at -38.8%
  • NET SALES(Q) Lowest at Rs 38.28 cr
  • PBDIT(Q) Lowest at Rs 4.85 cr.
3
Stock is technically in a Bearish range
  • The technical trend has deteriorated from Mildly Bearish on 28-Feb-25 and has generated 15.1% returns since then
  • The stocks MACD and KST technical factors are also Bearish
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Titan Biotech for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Titan Biotech
-5.52%
-0.08
60.29%
SENSEX
0.45%
0.03
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
16.04%
EBIT Growth (5y)
18.00%
EBIT to Interest (avg)
24.96
Debt to EBITDA (avg)
0.29
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.33
Tax Ratio
24.74%
Dividend Payout Ratio
6.65%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
31.51%
ROE (avg)
26.48%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
18
Industry P/E
41
Price to Book Value
2.79
EV to EBIT
16.72
EV to EBITDA
14.23
EV to Capital Employed
2.89
EV to Sales
2.47
PEG Ratio
NA
Dividend Yield
0.41%
ROCE (Latest)
21.71%
ROE (Latest)
17.43%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
CASH AND CASH EQUIVALENTS(HY)

Highest at Rs 10.03 cr

-14What is not working for the Company
PAT(Q)

At Rs 4.39 cr has Fallen at -38.8%

NET SALES(Q)

Lowest at Rs 38.28 cr

PBDIT(Q)

Lowest at Rs 4.85 cr.

OPERATING PROFIT TO NET SALES (Q)

Lowest at 12.67%

PBT LESS OI(Q)

Lowest at Rs 3.51 cr.

EPS(Q)

Lowest at Rs 5.31

Loading Valuation Snapshot...
Here's what is working for Titan Biotech
Cash and Cash Equivalents - Half Yearly
Highest at Rs 10.03 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Here's what is not working for Titan Biotech
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 3.51 cr has Fallen at -63.05%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 4.39 cr has Fallen at -38.8%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Net Sales - Quarterly
At Rs 38.28 cr has Fallen at -16.75%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (Rs Cr)

Net Sales - Quarterly
Lowest at Rs 38.28 cr
in the last five quarters
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Lowest at Rs 4.85 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Lowest at 12.67%
in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 3.51 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Earnings per Share (EPS) - Quarterly
Lowest at Rs 5.31
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)

Non Operating Income - Quarterly
Highest at Rs 1.59 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."